Advancing Transplantation Tolerance in Nonhuman Primates
- Institution
- UNIVERSITY OF MINNESOTA, MN
- Principal investigator
- Andrew B Adams
- Funding
- $113K
- Duration
- 2023–2028
Moonbase score
Still being scored
Abstract
The Administrative Core Abstract: The main objective of the Administrative Core is to facilitate the project’s successful completion by organizing and coordinating the non-scientific aspects of the studies that comprise this proposal. This program involves multiple institutions, academic departments, industry organizations, facilities, and investigators. The Administrative Core will be responsible for organizing and coordinating the regulatory requirements, administrative support structures, financial models, standard operating protocols, sample analysis and data storage aspects of this study. We will coordinate with the representatives from each institution to ensure that each element of this core proposal provided to them in an efficient and organized manner. The importance of Administrative Core lies in the fact that it will be the central interface that bonds together each of the three projects. We believe that this bond will propel the projects and cores to carry out the specific aims efficiently. Our past experiences, with clinical and translational research consortia have led us to realize the importance of a strong administrative core in order to achieve our scientific goals
LOADING MOONBASE SCORE
Questions for UNIVERSITY OF MINNESOTA
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · University of MinnesotaNot yet scored
Advancing Transplantation Tolerance in Nonhuman Primates
Andrew B Adams · $3.6M · 2023–2028
- NIH · University of MinnesotaNot yet scored
Promoting Kidney Transplantation Tolerance Through Novel Immunomodulation and Cellular Therapy
Andrew B Adams · $770K · 2023–2028
- NIH · University of MinnesotaNot yet scored
Strategies to Optimize Pig-to-Primate Kidney Xenograft Survival
Andrew B Adams · $1.6M · 2016–2030